Cargando…
Long-term Follow-up of a Randomized Trial of Tacrolimus or Cyclosporine A Microemulsion in Children Post Liver Transplantation
The aim of this study was to determine the long-term efficacy and safety of tacrolimus (Tac) and cyclosporine immunosuppression in pediatric liver transplantation (LTx). METHODS. One hundred fifty-six patients who had taken part in a multicenter, randomized, open, parallel study of Tac and corticost...
Autores principales: | Lloyd, Carla, Arshad, Adam, Jara, Paloma, Burdelski, Martin, Gridelli, Bruno, Manzanares, J., Colledan, Michele, Jacquemin, Emmanuel, Reding, Raymond, Baumann, Ulrich, Kelly, Deirdre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454910/ https://www.ncbi.nlm.nih.gov/pubmed/34557582 http://dx.doi.org/10.1097/TXD.0000000000001221 |
Ejemplares similares
-
Results of the TOP Study: Prospectively Randomized Multicenter Trial of an Ex Vivo Tacrolimus Rinse Before Transplantation in EDC Livers
por: Pratschke, Sebastian, et al.
Publicado: (2016) -
Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus
por: Okumura, Yuichiro, et al.
Publicado: (2017) -
Sequential Cohort Analysis After Liver Transplantation Shows de Novo Extended Release Tacrolimus Is Safe, Efficacious, and Minimizes Renal Dysfunction
por: Lim, Tiong Yeng, et al.
Publicado: (2020) -
Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study
por: Friman, Styrbjörn, et al.
Publicado: (2021) -
ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities
por: Shagrani, Mohammad, et al.
Publicado: (2022)